Anton Simeonov

2000–2025 年に発表

194
論文数
22,158
被引用数
86
h 指数
187
i10 指数

被引用数

Anton Simeonov の年別被引用数1900 年: 被引用 1 件1998 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 8 件2004 年: 被引用 7 件2005 年: 被引用 2 件2006 年: 被引用 6 件2007 年: 被引用 23 件2008 年: 被引用 81 件2009 年: 被引用 135 件2010 年: 被引用 130 件2011 年: 被引用 153 件2012 年: 被引用 155 件2013 年: 被引用 134 件2014 年: 被引用 199 件2015 年: 被引用 207 件2016 年: 被引用 248 件2017 年: 被引用 275 件2018 年: 被引用 305 件2019 年: 被引用 851 件2020 年: 被引用 1,219 件2021 年: 被引用 1,340 件2022 年: 被引用 1,095 件2023 年: 被引用 818 件2024 年: 被引用 1,165 件2025 年: 被引用 532 件2026 年: 被引用 48 件1901〜1997 年は被引用が無いため表示していません1999〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,307 件、この内訳の 28%中国: 引用元論文 1,393 件、この内訳の 11.8%イギリス: 引用元論文 805 件、この内訳の 6.8%ドイツ: 引用元論文 624 件、この内訳の 5.3%カナダ: 引用元論文 405 件、この内訳の 3.4%イタリア: 引用元論文 355 件、この内訳の 3%インド: 引用元論文 343 件、この内訳の 2.9%フランス: 引用元論文 313 件、この内訳の 2.6%オーストラリア: 引用元論文 254 件、この内訳の 2.1%スウェーデン: 引用元論文 247 件、この内訳の 2.1%スイス: 引用元論文 245 件、この内訳の 2.1%スペイン: 引用元論文 238 件、この内訳の 2%
0%28%その他 27.9%

分野

  • Biochemistry, Genetics and Molecular Biology39.7%
  • Medicine26.3%
  • Computer Science16.7%
  • Immunology and Microbiology4.9%
  • Chemistry3.1%
  • Engineering2%
  • その他7.3%

トピック

  • Computational Drug Discovery Methods8%
  • Epigenetics and DNA Methylation2.5%
  • SARS-CoV-2 and COVID-19 Research2.2%
  • Histone Deacetylase Inhibitors Research1.5%
  • COVID-19 Clinical Research Studies1.5%
  • Bioinformatics and Genomic Networks1.5%
  • その他82.8%

共著者

全論文

検索で開く
  1. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nathan Pate, Mones Abu‐Asab, Marc Ferrer, Noel Southall, Chan-Young Ock, Yongmei Zhao, Henry Lopez, Serguei Kozlov, Natalia de Val, Clayton Yates, Bolormaa Baljinnyam, Juan Marugán, Udo Rudloff - Science Translational Medicine 2020 被引用: 426

  2. The Tox21 10K Compound Library: Collaborative Chemistry Advancing Toxicology

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Chemical Research in Toxicology 2020 被引用: 310

  3. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

    著者: , , , , , , - ACS Central Science 2020 被引用: 975

  4. Tox21Challenge to Build Predictive Models of Nuclear Receptor and Stress Response Pathways as Mediated by Exposure to Environmental Chemicals and Drugs

    著者: , , , , , , , , - Frontiers in Environmental Science 2016 被引用: 213

  5. The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics

    著者: , , , , , , , , , , , , - Frontiers in Pharmacology 2019 被引用: 320

  6. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 被引用: 254

  7. Unexplored therapeutic opportunities in the human genome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, D. Vidović, Anna Waller, David Westergaard, Jeremy J. Yang, Gergely Zahoránszky-Köhalmi - Nature Reviews Drug Discovery 2018 被引用: 385

  8. Pharos: Collating protein information to shed light on the druggable genome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2016 被引用: 318

  9. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy

    著者: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 被引用: 243

  10. KDM5 histone demethylases repress immune response via suppression of STING

    著者: , , , , , , , , , , , , , , , , , , , , , , , - PLoS Biology 2018 被引用: 166

  11. Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions

    著者: , , , , , , , , , , , , , , , , - Methods 2012 被引用: 632

  12. Large-Scale Modeling of Multispecies Acute Toxicity End Points Using Consensus of Multitask Deep Learning Methods

    著者: , , , , , , , , - Journal of Chemical Information and Modeling, J. Chem. Inf. Model. 2021 被引用: 100

  13. CATMoS: Collaborative Acute Toxicity Modeling Suite

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Feng Gao, Jeffery M. Gearhart, Garett Goh, Jonathan M. Goodman, Francesca Grisoni, Chris Grulke, Thomas Härtung, Matthew Hirn, Pavel Karpov, Alexandru Korotcov, Giovanna J. Lavado, Michael S. Lawless, Xinhao Li, Thomas Luechtefeld, Filippo Lunghini, Giuseppe Felice Mangiatordi, Gilles Marcou, Dan H. Marsh, Todd M. Martin, Andrea Mauri, Eugene Muratov, Glenn J. Myatt, Ðắc-Trung Nguyễn, Orazio Nicolotti, Reine Note, Paritosh Pande, Amanda K. Parks, Tyler Peryea, Ahsan Habib Polash, Robert Ralló, Alessandra Roncaglioni, Craig Rowlands, Patricia Ruiz, Daniel P. Russo, Ahmed E Sayed, Risa Sayre, Timothy Sheils, Charles Siegel, Arthur C. Silva, Anton Simeonov, Sergey Sosnin, Noel Southall, Judy Strickland, Yun Tang, Brian J. Teppen, Igor V. Tetko, Dennis Thomas, Valery Tkachenko, Roberto Todeschini, Cosimo Toma, Ignacio J. Tripodi, Daniela Trisciuzzi, Alexander Tropsha, Alexandre Varnek, Kristijan Vuković, Zhongyu Wang, Liguo Wang, Katrina M. Waters, Andrew J. Wedlake, Sanjeeva J. Wijeyesakere, Dan Wilson, Zijun Xiao, Hongbin Yang, Gergely Zahoránszky-Köhalmi, Alexey Zakharov, Fagen F. Zhang, Zhen Zhang, Tongan Zhao, Hao Zhu, Kimberley M. Zorn ほか 2 名 - Environmental Health Perspectives 2021 被引用: 141

  14. Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries

    著者: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 820

  15. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 被引用: 670

  16. TCRD and Pharos 2021: mining the human proteome for disease biology

    著者: , , , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2020 被引用: 176

  17. A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells

    著者: , , , , , , , , , , , , , , , , , - Nature Methods 2021 被引用: 186

  18. Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anton Simeonov, Larry A. Sklar, Jeffrey P. Norenberg, W. Marston Linehan, David J. Maloney, Chi V. Dang, Alex G. Waterson, Matthew D. Hall, Victor Darley‐Usmar, Murali C. Krishna, Leonard Μ. Neckers - Cell Reports 2020 被引用: 122

  19. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

    著者: , , , , , , , , , , , , , , , , - Nature Communications 2013 被引用: 324

  20. Erratum: Unexplored therapeutic opportunities in the human genome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anton Simeonov, Larry A. Sklar, Noel Southall, Susumu Tomita, Ilinca Tudose, Oleg Ursu, D. Vidović, Anna Waller, David Westergaard, Jeremy J. Yang, Gergely Zahoránszky-Köhalmi - Nature Reviews Drug Discovery 2018 被引用: 323

  21. A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses

    著者: , , , , , , , , , , , , , , , , , - Nature Chemical Biology 2014 被引用: 273

  22. Drug repurposing screens and synergistic drug‐combinations for infectious diseases

    著者: , , - British Journal of Pharmacology 2017 被引用: 264

  23. Fluorescence polarization assays in high-throughput screening and drug discovery: a review

    著者: , , , , , , - Methods and Applications in Fluorescence 2016 被引用: 219

  24. Gene expression analysis identifies global gene dosage sensitivity in cancer

    著者: , , , , , , , , , , , , , , , - Nature Genetics 2015 被引用: 367